selenious acid has been researched along with Ovarian Neoplasms in 4 studies
Selenious Acid: A selenium compound with the molecular formula H2SO3. It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, M | 1 |
| Kumaran, MN | 1 |
| Gounder, M | 1 |
| Gibbon, DG | 1 |
| Nieves-Neira, W | 1 |
| Vaidya, A | 1 |
| Hellmann, M | 1 |
| Kane, MP | 1 |
| Buckley, B | 1 |
| Shih, W | 1 |
| Caffrey, PB | 2 |
| Frenkel, GD | 2 |
| Rodriguez-Rodriguez, L | 1 |
| Liu, J | 1 |
| Li, J | 1 |
| Zhang, JF | 1 |
| Xin, XY | 1 |
| Ohkawa, K | 1 |
| Tsukada, Y | 1 |
| Dohzono, H | 1 |
| Koike, K | 1 |
| Terashima, Y | 1 |
1 trial available for selenious acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Phase I trial of selenium plus chemotherapy in gynecologic cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Lin | 2018 |
3 other studies available for selenious acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Combination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Prolife | 2013 |
Selenite cytotoxicity in drug resistant and nonresistant human ovarian tumor cells.
Topics: Cell Adhesion; Cell Division; Cell Survival; Drug Resistance; Female; Humans; In Vitro Techniques; O | 1992 |
The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Respons | 1988 |